Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, 60612, USA.
Breast. 2020 Jun;51:50-56. doi: 10.1016/j.breast.2020.02.009. Epub 2020 Mar 6.
The role of post mastectomy radiation therapy (PMRT) in patients with N1mic breast cancer has not been well defined. A retrospective analysis was performed using the SEER database to evaluate the impact of PMRT on survival in patients with N1mic breast cancer.
Women with T1-T2, N1mic, M0 breast cancer who had undergone mastectomy were analyzed. Descriptive statistics were calculated for all variables. Univariate analysis to assess for differences in survival with respect to covariates was performed using the log rank test while multivariate analysis was performed with Cox proportional hazards regression. Sub-cohort analysis with propensity score matching was used to assess differences in survival among patients undergoing PMRT vs no PMRT. Comparisons were considered statistically significant at P < 0.05.
Among 5878 patients, 1202 (20%) underwent PMRT. On univariate analysis, PMRT was a significant predictor of CSS, but not OS. There was no difference in either OS or CSS between the PMRT vs no PMRT groups on multivariate Cox regression analysis and after propensity score matching.
Among patients with T1-T2, N1mic, M0 breast IDC from the SEER database, there was no difference in either OS or CSS among patients who underwent PMRT vs no PMRT. These results suggest that PMRT does not impact survival among breast cancer patients with N1mic disease. However, additional prospective studies with longer follow up are necessary for further evaluation.
N1mic 乳腺癌患者术后放疗(PMRT)的作用尚未明确。本研究使用 SEER 数据库进行回顾性分析,旨在评估 PMRT 对 N1mic 乳腺癌患者生存的影响。
纳入 T1-T2、N1mic、M0 期行乳房切除术的女性患者。对所有变量进行描述性统计分析。使用对数秩检验进行单因素分析,以评估与协变量有关的生存差异,同时使用 Cox 比例风险回归进行多因素分析。采用倾向评分匹配进行亚组分析,以评估 PMRT 与非 PMRT 患者的生存差异。P<0.05 为差异有统计学意义。
5878 例患者中,有 1202 例(20%)接受了 PMRT。单因素分析显示,PMRT 是 CSS 的显著预测因子,但不是 OS。多因素 Cox 回归分析和倾向评分匹配后,PMRT 组与非 PMRT 组在 OS 或 CSS 方面均无差异。
SEER 数据库中 T1-T2、N1mic、M0 期 IDC 乳腺癌患者中,PMRT 组与非 PMRT 组在 OS 或 CSS 方面均无差异。这些结果表明,PMRT 不会影响 N1mic 疾病乳腺癌患者的生存。但是,需要进一步的评估,还需要进行具有更长随访时间的前瞻性研究。